Solu-Cortef

SECTION 2: Hazards identification

Appearance: White to off-white powder

Signal word

WARNING

Hazard statements

Suspected of damaging the unborn child.

Additional information

Short Term: May cause slight irritation ; May cause skin irritation. (based on components) . May be absorbed through the skin in harmful amounts. Central nervous system effects such as headache, dizziness, drowsiness, fatigue, and lack of muscular coordination can also occur. May cause stomach irritation, diarrhea, nausea, or vomiting. Long Term: Animal studies have shown a potential to cause adverse effects on the fetus. However, occupational handling of this product is not expected to result in relevant exposures. Known Clinical Effects: Effects on vision have been seen during clinical use. Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. Clinical use may cause an increase in blood pressure (hypertension). Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. EU Indication of danger: Toxic to Reproduction: Category 3 EU Hazard Symbols: EU Risk Phrases: R63 - Possible risk of harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.